Please use this identifier to cite or link to this item: http://elea.unisa.it:8080/xmlui/handle/10556/1646
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBerlot, Giorgio-
dc.contributor.authorRossini, Perla-
dc.contributor.authorTurchet, Federica-
dc.date.accessioned2015-01-29T12:49:43Z-
dc.date.available2015-01-29T12:49:43Z-
dc.date.issued2015-
dc.identifier.citationGiorgio Berlot, Perla Rossini, Federica Turchet. Biology of Immunoglobulins. Translational Medicine @ UniSa 2015, 11(4):24-27en_US
dc.identifier.issn2239-9747en_US
dc.identifier.urihttp://hdl.handle.net/10556/1646-
dc.identifier.urihttp://dx.doi.org/10.14273/unisa-450-
dc.description.abstractIntravenous Immunoglobulins (IvIg) are often administered to critically ill patients more as an act of faith than on the basis of relevant clinical studies. This particularly applies to the treatment of sepsis in adult patients, in whom the current guidelines even recommend against their use, despite that many studies demonstrated either their beneficial effects in different subsets of patients and that some preparations of IvIg are more effective than other. The biology of Ig are reviewed, aiming to a more in-depth understanding of their properties in order to clarify their possible indications in different clinical settings.en_US
dc.format.extentP. 24-27en_US
dc.language.isoenen_US
dc.sourceUniSa. Sistema Bibliotecario di Ateneoen_US
dc.subjectSepsisen_US
dc.subjectSeptic shocken_US
dc.subjectImmunoglobulinsen_US
dc.subjectInfectionsen_US
dc.titleBiology of Immunoglobulinsen_US
dc.typeArticleen_US
Appears in Collections:Translational Medicine @ UniSa. Volume 11 (jan.-apr. 2015)

Files in This Item:
File Description SizeFormat 
Berlot_G_Rossini_P_Turchet_F_Biology_of_Immunoglobulins.pdfarticolo di rivista132,32 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.